{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:27:05Z","timestamp":1785882425228,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Top-level Clinical Discipline Project of Shanghai Pudong District","award":["PWYgf2018-02"],"award-info":[{"award-number":["PWYgf2018-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patent ductus arteriosus (PDA) complicated by Eisenmenger syndrome (ES) remains to be a major cause of morbidity and mortality worldwide. Giving increasing evidences of benefit from targeted therapies, ES patients once thought to be inoperable may have increasing options for management. This study aims to explore whether PDA in patients with ES can be treated with transcatheter closure (TCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between August 2014 and July 2016, four of fifteen PDA-ES patients whose Qp\/Qs improved significantly and Qp\/Qs\u2009&gt;\u20091.5 after acute vasodilator testing with 100% oxygen were selected to receive TCC and pulmonary vasodilator therapy. PAH-targeted drugs were prescribed before and after occlusion for all. Trial occlusion was performed before permanent closure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The first TCC failed after initiation of PAH-targeted drugs for 6\u00a0months in four patients. After the medication was adjusted and extended to 12\u00a0months, TCC was performed for all without hemodynamic intolerances during perioperative period. Pulmonary artery systolic pressure (PASP) was significantly decreased (\u2265\u200940%) immediately after TCC. During a mean follow-up of 48\u2009\u00b1\u200914.70\u00a0months, there were a further decrease of PASPs in two patients, the other two showed improved pulmonary vascular resistance, WHO functional class and six-minute walking distance despite deteriorated PASP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Some selected PDA-ES patients might benefit from TCC and combined PAH-targeted drugs play a crucial role.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01795-5","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T08:04:14Z","timestamp":1606809854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transcatheter closure for patent ductus arteriosus in patients with Eisenmenger syndrome: to do or not?"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-8190","authenticated-orcid":false,"given":"Fadong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"issue":"6 Suppl","key":"1795_CR1","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1378\/chest.09-2861","volume":"137","author":"I Adatia","year":"2010","unstructured":"Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest. 2010;137(6 Suppl):52S-61S.","journal-title":"Chest"},{"issue":"23","key":"1795_CR2","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","volume":"31","author":"H Baumgartner","year":"2010","unstructured":"Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915\u201357.","journal-title":"Eur Heart J"},{"issue":"2","key":"1795_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0974-2069.99614","volume":"5","author":"PS Bhalgat","year":"2012","unstructured":"Bhalgat PS, Pinto R, Dalvi BV. Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension: short and intermediate term results. Ann Pediatr Cardiol. 2012;5(2):135\u201340.","journal-title":"Ann Pediatr Cardiol"},{"issue":"1","key":"1795_CR4","doi-asserted-by":"publisher","first-page":"e000744","DOI":"10.1136\/openhrt-2017-000744","volume":"5","author":"DL Varela","year":"2018","unstructured":"Varela DL, Teleb M, El-Mallah W. Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review. Open Heart. 2018;5(1):e000744.","journal-title":"Open Heart"},{"key":"1795_CR5","first-page":"16","volume":"21","author":"E Ereminien\u0117","year":"2017","unstructured":"Ereminien\u0117 E, Kinderyt\u0117 M, Miliauskas S, et al. Impact of advanced medical therapy for the outcome of an adult patient with Eisenmenger syndrome. Respir Med Case Rep. 2017;21:16\u201320.","journal-title":"Respir Med Case Rep"},{"issue":"1","key":"1795_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","volume":"121","author":"K Dimopoulos","year":"2010","unstructured":"Dimopoulos K, Inuzuka R, Goletto S, et al. Improved survival among patients with eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circ Circ. 2010;121(1):20\u20135.","journal-title":"Circ Circ"},{"issue":"5","key":"1795_CR7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3760\/cma.j.issn.0366-6999.20131959","volume":"127","author":"A Liu","year":"2014","unstructured":"Liu A, Li Z, Li X, et al. Midterm results of diagnostic treatment and repair strategy in older patients presenting with non restrictive ventricular septal defect and severe pulmonary artery hypertension. Chin Med J (Engl). 2014;127(5):839\u201344.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"1795_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ijcard.2012.02.007","volume":"167","author":"GP Diller","year":"2013","unstructured":"Diller GP, Alonso-Gonzalez R, Dimopoulos K, Alvarez-Barredo M, et al. Disease targeting therapies in patients with Eisenmenger syndrome: response to treatment and long-term efficiency. Int J Cardiol. 2013;167(3):840\u20137.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1795_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1253\/circj.CJ-13-1263","volume":"78","author":"PO Myers","year":"2014","unstructured":"Myers PO, Tissot C, Beghetti M. Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease. Circ J. 2014;78(1):4\u201311.","journal-title":"Circ J"},{"key":"1795_CR10","first-page":"e000","volume":"000","author":"CJ Daniels","year":"2018","unstructured":"Daniels CJ, Aboulhosn JA, et al. 2018 AHA\/ACC Guideline for the management of adults with congenital heart disease. Circulation. 2018;000:e000\u2013e000.","journal-title":"Circulation"},{"issue":"9","key":"1795_CR11","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.4187\/respcare.01418","volume":"57","author":"JB Huang","year":"2012","unstructured":"Huang JB, Liang J, Zhou LY. Eisenmenger syndrome: not always inoperable. Respir Care. 2012;57(9):1488\u201395.","journal-title":"Respir Care"},{"issue":"4","key":"1795_CR12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1053\/j.jvca.2013.04.023","volume":"28","author":"MJ Lanigan","year":"2014","unstructured":"Lanigan MJ, Chaney MA, Tissot C, et al. Eisenmenger syndrome: close the hole? J Cardiothorac Vasc Anesth. 2014;28(4):1146\u201353.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1795_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/heart.86.5.553","volume":"86","author":"W Budts","year":"2001","unstructured":"Budts W, Van Pelt N, Gillyns H, Gewillig M, Van de Werf F, Janssens S. Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome. Heart. 2001;86:553\u20138.","journal-title":"Heart"},{"issue":"1","key":"1795_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1747-0803.2011.00611.x","volume":"7","author":"M Beghetti","year":"2012","unstructured":"Beghetti M, Gali\u00e8 N, Bonnet D. Can, \u201cinoperable\u201d congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality? Congenit Heart Dis. 2012;7(1):3\u201311.","journal-title":"Congenit Heart Dis"},{"issue":"7","key":"1795_CR15","first-page":"1165","volume":"7","author":"Z Hu","year":"2015","unstructured":"Hu Z, Xie B, Zhai X, et al. Midterm results of \u201ctreat and repair\u201d for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension. J Thorac Dis. 2015;7(7):1165\u201373.","journal-title":"J Thorac Dis"},{"issue":"1","key":"1795_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1253\/circj.CJ-15-1235","volume":"80","author":"A Yao","year":"2016","unstructured":"Yao A. \u201cTreat-and-repair\u201d strategy for atrial septal defect and associated pulmonary arterial hypertension. Circ J. 2016;80(1):69\u201371.","journal-title":"Circ J"},{"issue":"9","key":"1795_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00392-014-0703-5","volume":"103","author":"MY Abd El Rahman","year":"2014","unstructured":"Abd El Rahman MY, Rentzsch A, Scherber P, et al. Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome A prospective, multicenter study using conventional and Speckle tracking echocardiography. Clin Res Cardiol. 2014;103(9):701\u201310.","journal-title":"Clin Res Cardiol"},{"issue":"17","key":"1795_CR18","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.105.603001","volume":"114","author":"S Mukhopadhyay","year":"2006","unstructured":"Mukhopadhyay S, Sharma M, Ramakrishnan S, et al. Phosphodiesterase-5 inhibitor in eisenmenger syndrome: a preliminary observational study. Circulation. 2006;114(17):1807\u201310.","journal-title":"Circulation"},{"issue":"17","key":"1795_CR19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/heartjnl-2014-305574","volume":"100","author":"M D'Alto","year":"2014","unstructured":"D\u2019Alto M, Diller GP. Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies. Heart. 2014;100(17):1322\u20138.","journal-title":"Heart"},{"issue":"5","key":"1795_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5090\/kjtcs.2017.50.5.378","volume":"50","author":"S Supomo","year":"2017","unstructured":"Supomo S, Hartopo AB, Anggrahini DW, et al. Large atrial septal defect closure in a patient with severe pulmonary arterial hypertension. Korean J Thorac Cardiovasc Surg. 2017;50(5):378\u201381.","journal-title":"Korean J Thorac Cardiovasc Surg"},{"issue":"3","key":"1795_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jocs.12325","volume":"29","author":"L Hu","year":"2014","unstructured":"Hu L, Tan L-H, Ye J. Repair of ventricular septal defect with Eisenmenger syndrome after Bosentan treatment. J Card Surg. 2014;29(3):401\u20132.","journal-title":"J Card Surg"},{"key":"1795_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/CIRCINTERVENTIONS.113.001135","volume":"7","author":"MD Duan-zhen Zhang","year":"2014","unstructured":"Duan-zhen Zhang MD, Xian-yang Zhu MD, Bei Lv MD, et al. Trial occlusion to assess the risk of persistent pulmonary arterial hypertension after closure of a large patent ductus arteriosus in adolescents and adults with elevated pulmonary artery pressure. Circ Cardiovasc Interv. 2014;7:473\u201381.","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"1795_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/S1047951115002772","volume":"27","author":"M Sadiq","year":"2017","unstructured":"Sadiq M, Rehman AU, Hyder N, et al. Intermediate- and long-term follow-up of device closure of patent arterial duct with severe pulmonary hypertension: factors predicting outcome. Cardiol Young. 2017;27(1):26\u201336.","journal-title":"Cardiol Young"},{"issue":"4","key":"1795_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/hrt.2006.091215","volume":"93","author":"C Yan","year":"2007","unstructured":"Yan C, Zhao S, Jiang S, et al. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart. 2007;93(4):514\u20138.","journal-title":"Heart"},{"issue":"3","key":"1795_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/heart.87.3.260","volume":"87","author":"BD Thanopoulos","year":"2002","unstructured":"Thanopoulos BD, Tsaousis GS, Djukic M, et al. Transcatheter closure of high pulmonary artery pressure patent ductus arteriosus with Amplatzer muscular ventricular septal occluder. Heart. 2002;87(3):260\u20133.","journal-title":"Heart"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01795-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T05:53:19Z","timestamp":1723960399000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01795-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1795"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01795-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-35445\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35445\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35445\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35445\/v4","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of Shanghai east hospital affiliated to Tongji University. Written informed consent was obtained from all individual participants prior to data collection","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from the patients for publication of this study. The copy of the written consents was available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"505"}}